Earnings History Data for Catalyst Biosciences (CBIO) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Catalyst Biosciences
Catalyst Biosciences, Inc. is a biopharmaceutical company which focused on creating and developing medicines to address serious medical conditions. The Company's hemostasis product candidates include CB 813d/PF-0520602, CB 2679d/ISU 304 and FXa. Anti-Complement Product consists of CB 2782 and Ophthalmic which are in clinical different trail. Catalyst Biosciences, Inc., formerly known as Targacept, Inc., is based in South San Francisco, Calif.
Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
26-10-2023 | AH | CBIO | Catalyst Biosciences | 16.00 | -0.04 | -0.05 | 0.00 | 0.5253 | -0.01 (-2.54%) |
0.52 | -0.02 (-3.34%) |
0.19 - 0.74 | 195,546 | 600,000 | 201 | |||
|
||||||||||||||||||
15-08-2022 | AH | CBIO | Catalyst Biosciences | 59.00 | -0.18 | -0.22 | 0.00 | Catalyst Biosciences GAAP EPS of $1.64 [8/15/2022 4:59 PM] |
1.90 | -0.03 (-1.55%) |
1.92 | -0.01 (-0.52%) |
0.35 - 5.20 | 160,377 | 320,000 | 3,280 | ||
09-05-2022 | PM | CBIO | Catalyst Biosciences | 15.00 | -0.46 | -0.56 | 0.00 | Catalyst Biosciences GAAP EPS of -$0.46 misses by $0.02, revenue of $0.8M [5/9/2022 8:49 AM] |
0.4350 | -0.06 (-11.42%) |
0.46 | -0.03 (-6.98%) |
0.43 - 5.20 | 230,108 | 130,000 | 101 | ||
12-11-2021 | PM | CBIO | Catalyst Biosciences, Inc. | 93.73 | -0.80 | -0.66 | -0.73 | Catalyst Biosciences EPS misses by $0.14, beats on revenue [11/12/2021 8:46 AM] |
1.72 | -1.22 (-41.50%) |
2.01 | -0.93 (-31.63%) |
1.66 - 7.55 | 5,275,092 | 210,000 | 560,421 | ||
|
||||||||||||||||||
06-05-2021 | PM | CBIO | Catalyst Biosciences, Inc. | 148.00 | -0.79 | -0.77 | 0.00 | Catalyst Biosciences EPS misses by $0.12, beats on revenue [5/6/2021 8:47 AM] |
4.53 | -0.11 (-2.37%) |
4.96 | 0.32 (6.90%) |
4.05 - 8.22 | 311,961 | 390,000 | 604 | ||
|
||||||||||||||||||
04-03-2021 | PM | 8:00 AM ET (Mar 4) |
CBIO | Catalyst Biosciences, Inc. | 188.39 | -0.86 | -0.89 | -1.23 | Catalyst Biosciences EPS misses by $0.26, beats on revenue [3/4/2021 9:04 AM] |
5.86 | -0.40 (-6.31%) |
6.20 | -0.06 (-0.96%) |
3.43 - 8.22 | 753,878 | 401,945 | 5,716 | |
05-11-2020 | PM | CBIO | Catalyst Biosciences, Inc. | 120.46 | -0.73 | -0.95 | -1.06 | Catalyst Biosciences EPS beats by $0.06 [11/5/2020 8:20 AM] |
5.81 | 0.25 (4.50%) |
5.29 | -0.27 (-4.86%) |
3.43 - 8.94 | 253,605 | 255,286 | 257 | ||
|
||||||||||||||||||
06-08-2020 | PM | CBIO | Catalyst Biosciences, Inc. | 117.31 | -0.96 | -1.05 | -1.15 | Catalyst Biosciences EPS misses by $0.07 [8/6/2020 9:07 AM] |
5.47 | 0.10 (1.91%) |
5.37 | 0.0 (0.00%) |
3.43 - 8.94 | 70,044 | 351,449 | 167 | ||
|